Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $11.05 USD
Change Today 0.00 / 0.00%
Volume 6.1K
MSON On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 5:20 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

misonix inc (MSON) Snapshot

Open
$11.03
Previous Close
$11.05
Day High
$11.05
Day Low
$10.32
52 Week High
10/28/14 - $14.90
52 Week Low
09/4/14 - $6.51
Market Cap
85.6M
Average Volume 10 Days
19.8K
EPS TTM
$0.64
Shares Outstanding
7.7M
EX-Date
--
P/E TM
17.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for MISONIX INC (MSON)

Related News

No related news articles were found.

misonix inc (MSON) Related Businessweek News

No Related Businessweek News Found

misonix inc (MSON) Details

Misonix, Inc., a surgical device company, designs, manufactures, and markets therapeutic ultrasonic products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications worldwide. It offers BoneScalpel, an ultrasonic bone cutting system for use in surgical procedures of the spine, and in maxillofacial procedures; SonaStar surgical aspirator to emulsify and remove soft and hard tumors; and SonicOne, an ultrasonic cleansing and debridement system that provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. The company sells its products through direct sales persons, sales agents, and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

80 Employees
Last Reported Date: 08/20/15
Founded in 1959

misonix inc (MSON) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $390.0K
Chief Financial Officer, Senior Vice Presiden...
Total Annual Compensation: $246.0K
Vice President of Operations
Total Annual Compensation: $139.2K
Vice President of Research & Development and ...
Total Annual Compensation: $189.9K
Senior Vice President of Global Sales and Mar...
Total Annual Compensation: $255.1K
Compensation as of Fiscal Year 2015.

misonix inc (MSON) Key Developments

Misonix, Inc. Presents at 2015 Sidoti Emerging Growth Conference, Sep-02-2015 10:00 AM

Misonix, Inc. Presents at 2015 Sidoti Emerging Growth Conference, Sep-02-2015 10:00 AM. Venue: Marriott Marquis in Times Square, New York, New York, United States. Speakers: Michael A. McManus, Chairman, Chief Executive Officer, President and Member of Non-Employee Stock Option Committee, Richard A. Zaremba, Chief Financial Officer, Senior Vice President, Treasurer and Secretary.

Misonix Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended June 30, 2015

Misonix Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended June 30, 2015. For the quarter, the company reported net sales of $6,749,436 compared to $5,578,147 a year ago. Loss from operations was $42,253 compared to income from operations of $234,238 a year ago. Income from continuing operations before income taxes was $984,113 compared to $1,404,154 a year ago. Net income from continuing operations was $3,824,968 or $0.50 per diluted share compared to $1,387,400 or $0.19 per diluted share a year ago. Net income was $3,832,437 or $0.46 per diluted share compared to $1,389,193 or $0.18 per diluted share a year ago. The increase was primarily attributable to a 48% increase in BoneScalpel revenue to $3.7 million and a 99% increase in SonicOne revenue to $985,000. For the year, the company reported net sales of $22,204,578 compared to $17,060,435 a year ago principally attributable to an increase of 44% in BoneScalpel revenue to $11.1 million, a 14% increase in SonaStar revenue to $7.2 million and a 47% increase in SonicOne revenue to $3.3 million. Loss from operations was $1,714,939 compared to $2,548,964 a year ago. Income from continuing operations before income taxes was $5,304,056 compared to $1,157,210 a year ago. Net income from continuing operations was $15,304,056 or $0.70 per diluted share compared to $1,126,580 or $0.15 per diluted share a year ago. Net income was $5,571,171 or $0.69 per diluted share compared to $1,393,299 or $0.19 per diluted share a year ago.

Misonix, Inc. to Report Q4, 2015 Results on Aug 20, 2015

Misonix, Inc. announced that they will report Q4, 2015 results at 4:30 PM, US Eastern Standard Time on Aug 20, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSON:US $11.05 USD 0.00

MSON Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bovie Medical Corp $2.40 USD 0.00
IRIDEX Corp $6.86 USD -0.02
MGC Diagnostics Corp $5.50 USD -0.0247
Synergetics USA Inc $6.57 USD +0.01
Utah Medical Products Inc $53.21 USD +0.88
View Industry Companies
 

Industry Analysis

MSON

Industry Average

Valuation MSON Industry Range
Price/Earnings 16.9x
Price/Sales 3.8x
Price/Book 3.6x
Price/Cash Flow 15.4x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MISONIX INC, please visit www.misonix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.